SynAct Pharma AB (SYNACT) — Strategic Asset Allocation Index
SynAct Pharma AB (SYNACT) has a Strategic Asset Allocation Index of 0.4% as of June 2023. Strategic assets (PP&E of Skr993.00K plus long-term investments of Skr-) total Skr993.00K, measured against net assets of Skr241.50 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
SynAct Pharma AB Strategic Asset Allocation Index (2021–2022)
This chart shows how SynAct Pharma AB's Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of June 2023, the index stands at 0.4%, representing strategic assets of Skr993.00K against net assets of Skr241.50 Million SEK. Explore SYNACT cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for SynAct Pharma AB (2021–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for SynAct Pharma AB from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see SynAct Pharma AB stock valuation.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.7% | Skr2.10 Million | Skr2.10 Million | Skr- | Skr126.52 Million | ▼ -13.6 pp |
| 2021 | 15.2% | Skr3.18 Million | Skr3.18 Million | Skr- | Skr20.87 Million | — |